The study by Wei et al. 41 indicated that H19 functioned as a competing endogenous RNA (ceRNA) to modulate HER2 expression by antagonizing let-7c in GC, providing other potential H19-based therapeutic strategies for GC (Fig. 1E). This evidence concerns the gene ERBB2 and gastric cancer.